International Clinical Trial: A real-world study on the generic drug of nifedipine controlled-release tablets and the original drug (Bystolic)

Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125103) titled 'A real-world study on the generic drug of nifedipine controlled-release tablets and the original drug (Bystolic)' on May 21.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: West China Hospital, Sichuan University

Condition: This study will collect patients with essential hypertension who have taken nifedipine controlled-release tablets, either generic or originator drugs, from August 1, 2023, to July 31, 2025.

Intervention: generic drug of nifedipine controlled-release tablets:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-05-29

Target Sa...